bes has been researched along with ticagrelor in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angiolillo, DJ; Baber, U; Cao, D; Cohen, DJ; Collier, T; Dangas, GD; Escaned, J; Franzone, A; Gibson, CM; Goel, R; Huber, K; Kastrati, A; Kaul, U; Kornowski, R; Krucoff, M; Kunadian, V; Mehran, R; Mehta, SR; Moliterno, D; Owen, R; Pocock, S; Sartori, S; Sharma, SK; Spirito, A; Steg, GP; Valgimigli, M; Vranckx, P; Windecker, S; Yaling, H; Zhang, Z | 1 |
1 review(s) available for bes and ticagrelor
| Article | Year |
|---|---|
Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of GLASSY and TWILIGHT.
Topics: Absorbable Implants; Acute Coronary Syndrome; Drug-Eluting Stents; Humans; Percutaneous Coronary Intervention; Polymers; Sirolimus; Stents; Ticagrelor; Treatment Outcome | 2023 |